Nathaniel Katz

Nathaniel Katz holds the position of Chief Science Officer at Vital Clinical Solutions since March 2025, where the focus is on developing AI-based tools to enhance TMF audits and streamline the creation of new therapeutics. In addition, Katz serves as President of Ein Sof Innovation, a consulting firm specializing in clinical trials for painful disorders, and as Chief Medical Officer at Chariton Pharmaceuticals, a start-up biotech firm working on innovative HPMA-dexamethasone treatments for rheumatoid arthritis. Katz also provides expertise as a Senior Scientific Advisor at WCG. An academic presence includes roles as an Associate Professor and former Assistant Professor of Anesthesiology at Tufts University School of Medicine, coupled with significant experience as the owner and CEO of Analgesic Solutions. Educational credentials include a Doctor of Medicine from the Medical College of Pennsylvania and a Master’s degree in Biostatistics from Columbia University Mailman School of Public Health, among other qualifications in the field of medicine and yoga.